A detailed history of Capital World Investors transactions in Xenon Pharmaceuticals Inc. stock. As of the latest transaction made, Capital World Investors holds 2,681,537 shares of XENE stock, worth $104 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
2,681,537
Previous 2,681,537 -0.0%
Holding current value
$104 Million
Previous $105 Million 0.92%
% of portfolio
0.02%
Previous 0.02%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024

BUY
$28.7 - $46.46 $11.7 Million - $18.9 Million
406,563 Added 17.87%
2,681,537 $124 Million
Q4 2021

Feb 14, 2022

BUY
$15.6 - $35.4 $20.5 Million - $46.4 Million
1,311,474 Added 136.12%
2,274,974 $71.1 Million
Q3 2018

Nov 14, 2018

SELL
$9.0 - $14.9 $4.19 Million - $6.94 Million
-465,500 Reduced 32.58%
963,500 $12.7 Million
Q3 2017

Nov 14, 2017

BUY
$2.45 - $3.25 $3.5 Million - $4.64 Million
1,429,000
1,429,000 $4.22 Million

Others Institutions Holding XENE

About Xenon Pharmaceuticals Inc.


  • Ticker XENE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,263,500
  • Market Cap $2.41B
  • Description
  • Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopath...
More about XENE
Track This Portfolio

Track Capital World Investors Portfolio

Follow Capital World Investors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital World Investors, based on Form 13F filings with the SEC.

News

Stay updated on Capital World Investors with notifications on news.